Scientists probe immune system in severe COVID-19 to find new clues

NCT ID NCT04392401

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 200 adults with COVID-19 in intensive care to see how their immune systems change over time. Researchers will collect blood samples at several points during the hospital stay and track health outcomes. The goal is to understand why some patients get worse and to find new ways to treat or prevent severe illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help identify new treatments and biological markers to better manage COVID-19 in intensive care.
What could go wrong
This is an observational study, not testing a treatment. It may not directly lead to new therapies, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTENSIVE CARE UNIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH de St Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, 42055, France

  • Centre hospitalier universitaire de Grenoble Alpes

    NOT_YET_RECRUITING

    Grenoble, 38043, France

  • Hôpial de la Croix Rousse

    RECRUITING

    Lyon, 69004, France

  • Hôpital Edouard Herriot

    RECRUITING

    Lyon, 69003, France

  • Hôpital Edouard Herriot

    RECRUITING

    Lyon, 69003, France

  • Hôpital Gabriel Montpied

    NOT_YET_RECRUITING

    Clermont-Ferrand, 63000, France

  • Hôpital Lyon Sud

    RECRUITING

    Pierre-Bénite, 69310, France

  • Hôpital Pierre Wertheimer

    RECRUITING

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.